Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, ...
Leadership
Jason Tardio M.B.A.
COO & President
Daniel Vitt Ph.D.Founder
Founder & Director
Glenn Whaley CPA
Chief Financial Officer
Erik Lundgren
Chief Executive Officer
Hella Kohlhof
Chief Scientific Officer
Jessica Breu
Vice President of Investor Relations & Communications
